Carlisle Companies Inc (CSL)

393.73 -3.46%

Carlisle Companies Inc (CSL) is currently trading at $393.73. This represents a loss of 3.46% from the previous session. With a market capitalization of $16.10B, CSL is a key component of the Industrials sector. Investors looking to trade CSL should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade CSL commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Carlisle Companies Inc (CSL) shows a bearish trend. Analysts are watching the 412.05 level closely.

Fundamentals
Mkt Cap16.10B
P/E Ratio0.0000
Volume434,818
Others Watching (By Market Cap)
NUE
Nucor Corp $175.48
+0.17% ODFL
Old Dominion Fr $191.70
-2.54% VMC
Vulcan Material $305.53
-3.89% RKLB
Rocket Lab Corp $70.20
+0.33% ROP
Roper Technolog $344.24
+1.94%
60-Day Technical Chart
Advanced Charting

Need more indicators for CSL? Use the world's #1 platform.

Open CSL on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $394
Metric CSL
-3.46% 		TSLA
+1.94% 		MSFT
+2.98% 		MU
+2.63%
Price $393.73 $417.33 $400.64 $429.00
Mkt Cap $16.10B $1,307.69B $2,974.97B $482.84B
- View → View → View →
Latest Headlines
CSL share price slips again as buyback rolls on, March dividend date looms TechStock² • Feb 24, 2026 Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings CNBC • Feb 10, 2026 CSL Shares Tumble to Eight-Year Low After First-Half Profit Miss Bloomberg.com • Feb 10, 2026 CSL share price ticks up after buyback update — now the dividend clock starts to matter Bez Kabli • Feb 25, 2026 Breakingviews - Biotech CSL fails at administering own medicine Reuters • Feb 10, 2026
● Gemini Agentic AI Analyst Insight for CSL
Market Education
View All Articles →
External Research